Integrated Genomics, Inc. Release: Evonik Industries Licenses ERGOTM Genomics Platform for Specialty Chemicals Optimization Research Using Microbial Genomes
11/10/2008 8:54:26 AM
CHICAGO & MARL, Germany--(BUSINESS WIRE)--Integrated Genomics, Inc., a leader in microbial genomic informatics, has licensed the ERGO™ genomics platform for use in research and production systems to Evonik Industries, a global leader in specialty chemicals. Under the terms of the agreement, scientists of the Evonik Science-to-Business Center Biotechnology will use the ERGO™ system to optimize their production strains and find new methods for high yield production of specialty chemicals.
comments powered by